Exagen Inc. ã¯ãç±³åœã§ AVISE ãã©ã³ããšããŠã现èçµåè£äœæŽ»æ§å補åæè¡ã«åºã¥ãããŸããŸãªæ€æ»è£œåãéçºãåååããŠããŸãããã®è£œåã«ããããªãŠããå°éå»ã¯ãå
šèº«æ§ãšãªããããŒãã¹ (SLE) ããã³é¢ç¯ãªãŠãã (RA) ã®èšºæãäºåŸãã¢ãã¿ãªã³ã°ãéããŠæ£è
ã®ã±ã¢ã匷åã§ããŸããäž»åã®æ€æ»è£œå㯠AVISE CTD ã§ãããŸããŸãªçµåçµç¹çŸæ£ (CTD) ããã³éè€ããçç¶ã䌎ããã®ä»ã®é¢é£çŸæ£ã瀺åããçç¶ãåããæ£è
ã®éå¥èšºæãå¯èœã§ããå瀟ã®è£œåã«ã¯ãæ£è
ã®è¡æ¶²äžã® B 现è C4d ããã³èµ€è¡ççµå C4d ã®ã¬ãã«ãå®éåããããšã§è£äœç³»ã®æŽ»æ§åãæž¬å®ãã AVISE Lupusãããã³ APS ã®èšºæãšç®¡çã«åœ¹ç«ã€ 8 ã€ã®èªå·±æäœæ€æ»ããã«ã§æ§æããã AVISE APS ããããŸããããã«ãå瀟ã¯ãè
èãè³ãå¿è¡ç®¡ç³»ã«åœ±é¿ãåãŒãå䜵çã®å¯èœæ§ãè©äŸ¡ããããã®èªå·±æäœã®10ãã€ãªããŒã«ãŒããã«ã§ããAVISE SLE Prognosticãåã
ã®åæç©ã®æ€æ»ããã«ã䜿çšããŠæå¥œäžç现è質æäœã®è©äŸ¡ãšç£èŠã«ãããŠè¿
éãã€ä¿¡é Œæ§ã®é«ãçµæãå»åž«ã«æäŸããAVISE Vasculitis AAVãéçRAæ£è
ãç¹å®ããAVISE Anti-CarPæ€æ»ãããã³è¡å°æ¿çµåC4dãæž¬å®ããAVISE PC4dãæäŸããŠããŸããããã«ãå瀟ã¯ã6ãã€ãªããŒã«ãŒè¡æ¶²æ€æ»ã§ããAVISE SLE Monitorãç¹èš±ååŸæžã¿ã§æ€èšŒæžã¿ã®è¡æ¶²æ€æ»ã§ããAVISE MTXãããã³ããããã·ã¯ãããã³ã®ã¬ãã«ãç£èŠããè¡æ¶²æ€æ»ã§ããAVISE HCQãæäŸããŠããŸããå瀟ã¯ãAllegheny Health NetworkïŒAHNïŒç ç©¶æããã³AHN Autoimmunity Instituteãšå
±åç ç©¶ããã³ã©ã€ã»ã³ã¹å¥çŽãç· çµããæ°ããç¹èš±ååŸæžã¿ãã€ãªããŒã«ãŒãéçºããŠããŸããå瀟ã¯ä»¥åã¯Exagen Diagnostics, Inc.ãšããŠç¥ãããŠããŸãããã2019幎1æã«Exagen Inc.ã«ç€Ÿåã倿ŽããŸãããExagen Inc.ã¯2002幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãã¹ã¿ã«æ¬ç€Ÿã眮ããŠããŸãã